Main Article Content


Background. The COVID-19 pandemic has added an additional burden in countries with already fragile health systems. Our objective was to determine the prevalence and seroprevalence of COVID-19 in suspected malaria during the second wave in Yaounde. Methods. A descriptive cross-sectional study was conducted at the Jordan Medical Services for 8 weeks from April 19 to June 13, 2021, i.e., during the second wave in Cameroon. For the 86 patients with suspected malaria, nasopharyngeal and blood samples were taken for SARS-CoV-2 antigen and anti-SARS-CoV-2 IgG and IgM using the STANDARD TM Q COVID-19 Ag kit from SD BIOSENSOR, Korea, 2020 and Standard TM Q COVID 19 Ac IgG/IgM kit from SD BIOSENSOR, Korea, 2020 respectively. Confirmation of malaria was done by microscopic examination of stained blood smears. Results. Malaria was confirmed in 20.9% (18) of cases. The prevalences of COVID-19 and COVID-19/malaria co-infection were 8.1% and 0.9% respectively. Of the 25.6% (54) of patients with anti-COVID-19 IgM, no positive microscopic cases were found. On the other hand, a little more than half of the patients had IgG antibodies against COVID-19 whether they had a positive thick drop or not (56.0% (42/75) and 52.2% (71/136) respectively). Conclusion. In case of suspicion of malaria in a malaria area, it seems important to consider COVID-19 as a differential diagnosis.


Prevalence Seroprevalence COVID-19 Malaria Cameroon Prévalence Séroprévalence COVID-19 Paludisme Cameroun

Article Details

How to Cite
Esther Voundi-Voundi, Isabelle-Claire Mene Tenku, Junior Voundi-Voundi, Marie Paule Ngogang, Nadège Lylian Doumou A Mvomo, Christiane Medi-Sike, & Michel Toukam. (2023). Prevalence and Seroprevalence of Covid-19 in Suspected Malaria During the Second Wave in Yaounde, Cameroon. HEALTH SCIENCES AND DISEASE, 24(2 Suppl 1). Retrieved from


  1. Lu H, Stratton CW, Tang YW. Outbreak of Pneumonia of Unknown Etiology in Wuhan, China: The Mystery and The Miracle. J Med Virol. 2020; 92 (4): 401-402.
  2. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O and al. The Continuing 2019-NCOV Epidemic Threat of Novell Coronaviruses To Global Health - The latest 2019 Novel Coronavirus Outbreak in Wuhan, China. International journal of infectious diseases 2020 ; 91 : 264-266.
  3. World Health Organization: WHO Dashboard on Coronavirus (COVID-19).
  4. Bell D, Schultz Hansen K. Relative burden of covid-19 epidemics, malaria, tuberculosis and HIV / AIDS in sub-Saharan Africa. AM J LAV MED HYG. 2021; 105 (6): 1510-1515
  5. World Health Organization: Report 2021 on Malaria in the world-Info-Message Records.
  6. Ajayi IO, Ajumobi OO, Falad C. Malaria and Covid-19: Commonalities, Intersections and Implications for Sustaining Malaria Control. Pan Afr Med J. 2020 Sep 1, 37 (Suppl 1): 1
  7. Anyanwu Mu. The association between the prevalence of malaria and the mortality related to the COVID-19.BMC Infect say. 2021 Sep 19, 21 (1): 975
  8. Raham TF. Influence of cloud endemia and prevalence of tuberculosis on mortality due to the COVID-19.Public health. May 2021; 194: 33-35
  9. Kalungi A, Kinyanda E, Akena DH, Kaleebu P, Bisganga IM. Less severe cases of COVID-19 in Sub-Saharan Africa: could co-infection or a recent history of plasmodium falciparum infection be protective?. Frontiers in immunology 2021 ; 12: 565625
  10. Hussein MIH, Albashir AAD, Elawad OAMA, Homeida A. Malaria and COVID-19: unmasking their ties. Malaria journal 2020; 19 (1): 1-10
  11. Heuschen AK, Lu G, Razum O, Abdul-Mumin A, Sankoh O, Von Seidlein L and al. Public health-relevant consequences of the COVID-19 pandemic on malaria in sub-Saharan Africa: a scoping review. Malaria journal 2021; 20 (1): 339
  12. de Laval F, Maugey N, Bonet d’Oléon A, Pommier de Santi V, Ficko C. Increased risk of severe malaria in travellers during the COVID-19 pandemic. Journal of Travel Medicine 2021; 28 (6): taab106
  13. Pusparani A, Henrina J, Cahyadi A. Co-infection with COVID-19 and recurring malaria.J Infect Dev Ctries. 2021; 15 (5): 625-629
  14. Wilairaratana P, Masangkay EN, Kotepui KU, Milanez GJ, Kotepui M. Prevalence and malaria characteristics in people with COVID-19: Systematic Review, Meta-Analysis and Analysis of Case Reporting.PLOS Negl too dis here. 2021 Oct 1; 15 (10)
  15. WHO: boards for microscopic diagnosis of malaria. Geneva, World Health Organization, 2010
  16. SIDIBE, Dramane. Place du paludisme dans les étiologies des fièvres au CSCom de Dialakorodji Pays d’origine: Mali. 2021. Thèse de doctorat. USTTB.
  17. Touré M, Diallo CO, N’Zoue KS, Yobo-Bi MS, Kée Mankoh Y-C, Kamagaté M. Efficacy of artemisinin-based combinations therapies in real life use in uncomplicated Plasmodium falciparum malaria treatment in Côte d’Ivoire. Rev int sc méd Abj 2020; 22(3):169-180.
  18. Saoud MZ, Ezzariga N, Benaissa E, Moustachi A, Lyagoubi M, Aoufi S. Imported malaria: 54 cases diagnosed at the Ibn Sina Hospital Center in Rabat, Morocco. Med Sante Trop. 2019;29(2):159-163.
  19. Milner DA Jr. Malaria Pathogenesis. Cold Spring Harb Perspect Med. 2018 ; 8(1):a025569.
  20. Lechner M, Chandrasekharan D, Jumani K, Liu J, Gane S, Lund VJ and al. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers–a systematic review of the literature, case series, and recommendations for clinical assessment and management. Rhinology 2020; 58(4): 394-399.
  21. Mahalaxmi I, Kaavya J, Mohana Devi S, Balachandar V. COVID‐19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases. Journal of cellular physiology 2021; 236(2): 763-770.
  22. Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz R and al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. Journal of clinical medicine 2020; 9(6): 1753.
  23. Doutoum AA, Dongous DM, Gondimo EG, Laougangta RD, Adoum A, Garandi B. & Njintang NY. Prévalence et facteurs des risques associés au paludisme chez les patients de l’Hôpital Provincial d’Abéché (Tchad) [Prevalence and factors of risk halting patients in patients in the Abbut Provincial Hospital (Chad)]. International Journal of Biological and Chemical Sciences 2019; 13 (4), 1995-2004.
  24. Cisse M, Camara A, Fofana A, Lama E. Parcours du malade pour la recherche des soins contre le paludisme au niveau d’un district sanitaire [Pattern of the patient to seek care against malaria at a health district]. Infectious Diseases Now 2021; 51(5): S109-S110.
  25. Voundi EV, Mintya AN, Fokeng MG, Soppo Lobe CV, Ngo Nyeki AR., Beyala F and al. Mass screening of COVID 19 in a Yaoundé University Community from October to December 2020. Health Sci. Dis: 2021; 22 (12): 49-54.
  26. Igala M, Bivigou EA, Kombila UD, Ngoua SN, Ngomas JF, Mougougou A and al. Co-infection paludisme et COVID-19 chez les patients admis au service d’infectiologie COVID du Centre Hospitalier Universitaire de Libreville [Co-infection of malaria and COVID-19 in patients admitted to the COVID Infectious Disease Department of the Libreville University Hospital Center]. Pan Afr Med J. 2022 ; 41:101.

Most read articles by the same author(s)